Phenazine and quinoxaline substituted amino acids and polypeptides

Details for Australian Patent Application No. 2007341997 (hide)

Owner Ambrx, Inc.

Inventors Miao, Zhenwei

Agent FB Rice

Pub. Number AU-A-2007341997

PCT Pub. Number WO2008/083346

Priority 60/882,500 28.12.06 US

Filing date 28 December 2007

Wipo publication date 10 July 2008

International Classifications

C07D 241/40 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 487/12 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

2 July 2009 PCT application entered the National Phase

  PCT publication WO2008/083346 Priority application(s): WO2008/083346

9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007342005-N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as Axl inhibitors

2007341992-Crystalline forms of solvated ilaprazole